Ralf Bender
#185,358
Most Influential Person Now
Researcher
Ralf Bender's AcademicInfluence.com Rankings
Ralf Bendercomputer-science Degrees
Computer Science
#11957
World Rank
#12727
Historical Rank
Machine Learning
#5493
World Rank
#5567
Historical Rank
Artificial Intelligence
#5936
World Rank
#6026
Historical Rank
Database
#9041
World Rank
#9505
Historical Rank
Download Badge
Computer Science
Why Is Ralf Bender Influential?
(Suggest an Edit or Addition)Ralf Bender's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Methods to estimate the between‐study variance and its uncertainty in meta‐analysis† (2015) (743)
- Generating survival times to simulate Cox proportional hazards models (2005) (734)
- Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis (2010) (349)
- A General Regression Procedure for Method Transformation. Application of Linear Regression Procedures for Method Comparison Studies in Clinical Chemistry, Part III (1988) (261)
- Ordinal Logistic Regression in Medical Research (1997) (255)
- Calculating confidence intervals for the number needed to treat. (2001) (186)
- Calculating ordinal regression models in SAS and S-plus (2000) (124)
- Attention should be given to multiplicity issues in systematic reviews. (2008) (122)
- Methods to calculate uncertainty in the estimated overall effect size from a random‐effects meta‐analysis (2018) (105)
- Calculating the "number needed to be exposed" with adjustment for confounding variables in epidemiological studies. (2002) (102)
- Methods for evidence synthesis in the case of very few studies (2018) (99)
- Quantitative risk assessment in epidemiological studies investigating threshold effects (1999) (85)
- Common problems related to the use of number needed to treat. (2010) (72)
- Indirect Comparisons and Network Meta-Analyses. (2015) (60)
- The Peto odds ratio viewed as a new effect measure (2014) (58)
- Estimating adjusted NNT measures in logistic regression analysis (2007) (56)
- Causes of death in obesity: relevant increase in cardiovascular but not in all-cancer mortality. (2006) (52)
- Longitudinal changes in energy expenditure in an elderly German population: a 12-year follow-up (2009) (51)
- Introduction to the use of regression models in epidemiology. (2009) (51)
- Logistic regression models used in medical research are poorly presented (1996) (51)
- Calculating confidence intervals for impact numbers (2006) (49)
- A note on the graphical presentation of prediction intervals in random-effects meta-analyses (2012) (47)
- Breastfeeding promotion in non‐UNICEF‐certified hospitals and long‐term breastfeeding success in Germany (2003) (47)
- Body weight, blood pressure, and mortality in a cohort of obese patients. (2002) (43)
- On weakly informative prior distributions for the heterogeneity parameter in Bayesian random‐effects meta‐analysis (2020) (41)
- Unsolved issues of mixed treatment comparison meta‐analysis: network size and inconsistency (2012) (40)
- Calculation of NNTs in RCTs with time-to-event outcomes: A literature review (2009) (37)
- Eight-year trends in food, energy and macronutrient intake in a sample of elderly German subjects (2005) (37)
- GRADE guidelines 27: How to calculate absolute effects for time-to-event outcomes in Summary of Findings tables and Evidence Profiles. (2019) (35)
- Estimating adjusted risk difference (RD) and number needed to treat (NNT) measures in the Cox regression model (2010) (35)
- Effect of Berkson measurement error on parameter estimates in Cox regression models (2007) (33)
- Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence by H. Brenner and O. Gefeller, Statistics in Medicine, 16, 981-991 (1997) (1998) (31)
- Implementing GRADE: calculating the risk difference from the baseline risk and the relative risk (2013) (28)
- The number needed to treat in pairwise and network meta-analysis and its graphical representation. (2019) (27)
- Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs (2015) (27)
- Performance of the Peto odds ratio compared to the usual odds ratio estimator in the case of rare events (2016) (26)
- Generating survival times to simulate Cox proportional hazards models by Ralf Bender, Thomas Augustin and Maria Blettner, Statistics in Medicine 2005; 24:1713–1723 (2006) (24)
- Reporting of loss to follow-up information in randomised controlled trials with time-to-event outcomes: a literature survey (2011) (23)
- Factors of non-compliance with the therapeutic regimen among hypertensive men and women: A case-control study to investigate risk factors of stroke (2005) (22)
- Logistic regression was preferred to estimate risk differences and numbers needed to be exposed adjusted for covariates. (2010) (22)
- Biometrical issues in the analysis of adverse events within the benefit assessment of drugs (2016) (21)
- Methods to calculate relative risks, risk differences, and numbers needed to treat from logistic regression. (2010) (20)
- No inconsistent trial assessments by NICE and IQWiG: different assessment goals may lead to different assessment results regarding subgroup analyses. (2010) (20)
- A randomized trial comparing INR monitoring devices in patients with anticoagulation self-management: evaluation of a novel error-grid approach (2008) (17)
- The impact of non-compliance with the therapeutic regimen on the development of stroke among hypertensive men and women in Gaza, Palestine. (2004) (17)
- Tutorial: Using Confidence Curves in Medical Research (2005) (16)
- Estimating adjusted NNTs in randomised controlled trials with binary outcomes: a simulation study. (2010) (16)
- Flexible regression models are useful tools to calculate and assess threshold values in the context of minimum provider volumes. (2008) (15)
- Insulin glargine and cancer (2009) (15)
- Number Needed to Treat (NNT) (2005) (14)
- Fitting nonlinear regression models with correlated errors to individual pharmacodynamic data using SAS software (1995) (14)
- On the choice of the number of residual autocovariances for the portmanteau test of multivariate autoregressive models (1993) (14)
- Bias of Maximum-Likelihood estimates in logistic and Cox regression models: A comparative simulation study (2003) (13)
- Absolute risks rather than incidence rates should be used to estimate the number needed to treat from time-to-event data. (2013) (10)
- A new classification plot for the C-peptide suppression test. (2002) (9)
- Limitations of the incidence density ratio as approximation of the hazard ratio (2019) (8)
- Intervention Effects in the Case of Heterogeneity between Three Subgroups (2010) (8)
- A note on calculating asymptotic confidence intervals for the adjusted risk difference and number needed to treat in the Cox regression model (2014) (7)
- Confidence intervals for adjusted NNEs: a simulation study. (2003) (6)
- Calculating confidence intervals for summary measures of individual curves via nonlinear regression models. (1996) (5)
- A simulation study to compare different estimation approaches for network meta-analysis and corresponding methods to evaluate the consistency assumption (2020) (5)
- [Possibilities and limitations of statistical regression models for the calculation of threshold values for minimum provider volumes]. (2006) (5)
- Indirect Comparisons and Network Meta-Analyses Estimation of Effects in the Absence of Head-to-Head Trials — Part 22 of a Series on Evaluation of Scientific Publications (2015) (4)
- Using and Interpreting Adjusted NNT Measures in Biomedical Research. (2010) (4)
- [Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004]. (2006) (3)
- GRADE guidelines: 29. Rating the certainty in time-to-event outcomes - Study limitations due to censoring of participants with missing data in intervention studies. (2020) (3)
- Using and Interpreting Adjusted NNT Measures in Biomedical Research (2010) (3)
- Performing Meta-analyses with Very Few Studies. (2021) (3)
- Estimation of numbers needed to treat should be based on absolute risks. (2014) (2)
- The NNTnet metric is not new, not easy to use, and not routinely applied in medical research. (2020) (2)
- Adverse event development in clinical oncology trials. (2016) (2)
- Number Needed to Treat: Overview (2014) (2)
- Calculating Summary Measures of Unimodal Response Curves by Means of Nonlinear Regression Models (2000) (2)
- Adequate methods should be used to compare the features of effect measures. (2012) (1)
- Incorrect calculation of numbers needed to treat affects confidence intervals more often than point estimates. (2012) (1)
- A Review of: “Analysis of Clinical Trials Using SAS: A Practical Guide, by A. Dmitrienko, G. Molenberghs, C. Chuang-Stein, and W. Offen” (2006) (1)
- Performance of several types of beta-binomial models in comparison to standard approaches for meta-analyses with very few studies (2022) (1)
- Using common statistical program packages for the friedman test when there are ties among treatments and a multiple comparison procedure is needed (1993) (1)
- Improving the calculation of confidence intervals for the number needed to treat. (2000) (1)
- Summarizing empirical information on between-study heterogeneity for Bayesian random-effects meta-analysis. (2022) (1)
- [Interpretation of efficacy measures derived from 2 X 2 tables for the evaluation of diagnostic tests and treatment]. (2001) (1)
- Multiplicity issues in clinical trials (2011) (1)
- Network meta-analysis: an introduction (2008) (1)
- Multivariable Model-building. P. Royston and W. Sauerbrei (2008). New York: Wiley. ISBN: 978-0-470-02842-1 (2009) (0)
- The German approach to cost-effectiveness analysis in health care: a few rectifications based on the current situation as of early 2014. Comment on Hevér and Balogh (Society and Economy 35 (2013) 551-572) 1 (2014) (0)
- Letters and debate (2014) (0)
- S10.2: Time dependent exposure and age effects in Cox regression models – a simulation study (2004) (0)
- Contribution to the discussion of “When should meta‐analysis avoid making hidden normality assumptions?” (2018) (0)
- Involvement of information specialists and statisticians in systematic reviews (2023) (0)
- 016 Results Of A Case–control Study On Potential Risk Factors For The Development Of Stroke Among Factors Of Non-compliance With The Therapeutic Regimen In The Gaza Strip (2004) (0)
- ' s report Title : Estimating the BMI-Mortality Relationship : A New Approach Version : 1 Date : 12 July 2011 (0)
- S10.3: Examination of bias in Cox models due to Berkson measurement error in exposure (2004) (0)
- BOOK REVIEW (2005) (0)
- S41.1: A general approach to generate survival times in simulation studies (2004) (0)
- Guidances for statistics in regulatory affairs in Wikipedia: Initiative of the ISCB Statistics in Regulatory Affairs Subcommittee (SiRA SC) (2017) (0)
- Indirect Comparisons and Network Meta-Analysesof Effects in the Absence of Head-to-Head Trials—Part 22 of a Series on (2015) (0)
- The assessment of heterogeneity is mandatory in clinical trials and systematic reviews (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ralf Bender?
Ralf Bender is affiliated with the following schools:
